MT-TP and metabolic dysfunction-associated steatotic liver disease: Minor allele carriers of rs756998920 were not susceptible to type 2 diabetes (not shown), but further genetic studies are required to reveal whether heterozygotes for the functionally disrupting allele of MTTP have altered plasma TG levels and NAFLD risk.